Health CanadaGeneral Alert
Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk ...
Published: December 10, 2025Recall ID: 81344Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information
Product Description & Identification
Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk of Cerebral Edema in Primary Mediastinal B Cell Lymphoma (PMBCL)
Affected Products
Yescarta (axicabtagene ciloleucel) Suspension for Intravenous Infusion
Additional Source Details
| Field | Value |
|---|---|
| N I D | 81344 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-safety-information-yescarta-axicabtagene-ciloleucel-and-risk-cerebral-edema |
| Issue | New safety information |
| Title | Important Safety Information on Yescarta (axicabtagene ciloleucel) and the Risk of Cerebral Edema in Primary Mediastinal B Cell Lymphoma (PMBCL) |
| Product | Yescarta (axicabtagene ciloleucel) Suspension for Intravenous Infusion |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2025-12-10 |
| Organization | Marketed health products |